These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The genomic landscape of phaeochromocytoma. Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346 [TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis. Shi M; Whorton AE; Sekulovski N; Paquet M; MacLean JA; Song Y; Van Dyke T; Hayashi K Biol Reprod; 2020 Apr; 102(5):1055-1064. PubMed ID: 31930396 [TBL] [Abstract][Full Text] [Related]
12. Abnormalities in enzymes involved in catecholamine synthesis and catabolism in phaeochromocytoma. Jarrott B; Louis WJ Clin Sci Mol Med; 1977 Dec; 53(6):529-35. PubMed ID: 22422 [No Abstract] [Full Text] [Related]
13. Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer. Couto SS; Cao M; Duarte PC; Banach-Petrosky W; Wang S; Romanienko P; Wu H; Cardiff RD; Abate-Shen C; Cunha GR Differentiation; 2009 Jan; 77(1):103-11. PubMed ID: 19281769 [TBL] [Abstract][Full Text] [Related]
14. Tyrosine hydroxylase gene expression in varying forms of human pheochromocytoma. Tümer N; Brown JW; Carballeira A; Fishman LM Life Sci; 1996; 59(19):1659-65. PubMed ID: 8913331 [TBL] [Abstract][Full Text] [Related]
15. [Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991 [TBL] [Abstract][Full Text] [Related]
16. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425 [TBL] [Abstract][Full Text] [Related]
17. Development of pheochromocytoma in ceramide synthase 2 null mice. Park WJ; Brenner O; Kogot-Levin A; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH Endocr Relat Cancer; 2015 Aug; 22(4):623-32. PubMed ID: 26113602 [TBL] [Abstract][Full Text] [Related]
18. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging. Yong C; Moose DL; Bannick N; Gutierrez WR; Vanneste M; Svensson R; Breheny P; Brown JA; Dodd RD; Cohen MB; Henry MD PLoS One; 2020; 15(9):e0232807. PubMed ID: 32986721 [TBL] [Abstract][Full Text] [Related]
19. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948 [TBL] [Abstract][Full Text] [Related]
20. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses. Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]